[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Merck & Company (MRK)

Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Moderna Just Doubled on a Massive Cancer Breakthrough. Here’s Why MRNA Stock Isn’t a Buy Yet.

The last time you heard of Moderna (MRNA) was likely because of its mRNA Covid vaccine, but that same tech, once administered en masse, could soon become a life-changing, specialized cure for cancers. The recent breakthrough came from its intismeran autogene, or more formally mRNA-4157/V940, Moderna's personalized mRNA cancer therapy developed alongside Merck (MRK), which met its primary recurrence-free survival endpoint in a late-stage melanoma trial.

The result sent MRNA stock soaring 176.97% on Wednesday because intismeran autogene is designed around the unique mutations found in an individual patient's tumor and trains the immune system to recognize and attack...

Fundamentals

See More
  • Market Capitalization, $K 376,367,104
  • Shares Outstanding, K 2,467,172
  • Annual Sales, $ 65,011 M
  • Annual Income, $ 18,254 M
  • EBIT $ 6,984 M
  • EBITDA $ 12,822 M
  • 60-Month Beta 0.19
  • Price/Sales 5.65
  • Price/Cash Flow 13.04
  • Price/Book 8.76

Options Overview Details

View History
  • Implied Volatility 29.08% (-1.78%)
  • Historical Volatility 39.94%
  • IV Percentile 49%
  • IV Rank 53.94%
  • IV High 35.42% on 04/27/26
  • IV Low 21.66% on 12/08/25
  • Expected Move (DTE 5) 4.07 (2.67%)
  • Put/Call Vol Ratio 0.26
  • Today's Volume 79,390
  • Volume Avg (30-Day) 34,423
  • Put/Call OI Ratio 0.78
  • Today's Open Interest 560,806
  • Open Int (30-Day) 460,619
  • Expected Range 148.48 to 156.62

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 28 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $2.27
  • Number of Estimates 5
  • High Estimate $2.41
  • Low Estimate $2.20
  • Prior Year $2.58
  • Growth Rate Est. (year over year) -12.02%

Price Performance

See More
Period Period Low Period High Performance
1-Month
126.22 +20.86%
on 08/04/26
154.49 -1.26%
on 08/21/26
+26.29 (+20.82%)
since 07/21/26
3-Month
111.57 +36.73%
on 06/18/26
154.49 -1.26%
on 08/21/26
+36.67 (+31.64%)
since 05/21/26
52-Week
77.58 +96.64%
on 09/25/25
154.49 -1.26%
on 08/21/26
+66.47 (+77.22%)
since 08/21/25

Most Recent Stories

More News
Stocks Settle Higher as Crude Oil Prices Stabilize

The S&P 500 Index ($SPX ) (SPY ) closed up by +0.43% on Friday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up by +0.98%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up by +0.33%. E-mini...

MSTR : 119.25 (+6.10%)
TER : 375.74 (-1.93%)
AMAT : 492.32 (-0.78%)
B : 47.60 (+2.87%)
CNP : 38.77 (-3.56%)
SRE : 82.89 (-5.14%)
MRK : 152.55 (+2.39%)
$IUXX : 29,308.86 (+0.33%)
COIN : 186.49 (+8.20%)
ZNU26 : 108-085s (-0.22%)
TSLA : 362.86 (+5.14%)
ESU26 : 7,691.25s (+0.38%)
Moderna Just Doubled on a Massive Cancer Breakthrough. Here’s Why MRNA Stock Isn’t a Buy Yet.

Moderna's cancer treatment could treat more than just Melanoma, though the stock's momentum is already stalling. Should you still buy the dip?

MRK : 152.55 (+2.39%)
MRNA : 145.13 (+8.86%)
NVAX Stock Alert: Biotechs Hit Post-Pandemic High on mRNA Cancer Breakthrough

NVAX stock surges amid biotech stock rally following Moderna and Merck cancer breakthrough.

$NASX : 26,180.45 (+0.43%)
MRK : 152.55 (+2.39%)
NVAX : 8.94 (+6.18%)
MRNA : 145.13 (+8.86%)
XBI : 165.73 (+1.44%)
SNY : 45.85 (+1.55%)
BNTX : 116.57 (+5.12%)
Stocks Supported as Crude Oil Stabilizes

The S&P 500 Index ($SPX ) (SPY ) is up by +0.38% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up by +0.69%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +0.09%. E-mini S&P futures (ESU26...

MSTR : 119.25 (+6.10%)
TER : 375.74 (-1.93%)
AMAT : 492.32 (-0.78%)
B : 47.60 (+2.87%)
GLXY : 23.64 (+0.72%)
MRK : 152.55 (+2.39%)
$IUXX : 29,308.86 (+0.33%)
COIN : 186.49 (+8.20%)
ZNU26 : 108-085s (-0.22%)
ESU26 : 7,691.25s (+0.38%)
STX : 850.00 (-0.03%)
WDC : 459.44 (-2.05%)
Moderna’s 177% Surge Has Investors Asking What Comes Next

Moderna shares surged 177% after its melanoma vaccine, developed with Merck, outperformed an established therapy in a late-stage trial, triggering a massive short squeeze.

MRK : 152.55 (+2.39%)
MRNA : 145.13 (+8.86%)
Trump’s Moderna Trade Up Over 200% After Historic mRNA Cancer Vaccine Trial

Shares of Moderna ($MRNA) closed up nearly 177% at $174.38 on August 19 after the company and Merck ($MRK) announced positive Phase 3 results for their personalized mRNA cancer therapy, pushing Moderna's...

MRK : 152.55 (+2.39%)
MRNA : 145.13 (+8.86%)
Stocks Finish Mixed as Bond Yields Fall and Chipmakers Slide

The S&P 500 Index ($SPX ) (SPY ) closed up by +0.21% on Wednesday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up by +0.22%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.22%....

MSTR : 119.25 (+6.10%)
HL : 20.72 (-0.48%)
SNDK : 1,596.08 (-0.28%)
CDE : 20.97 (-0.66%)
GLXY : 23.64 (+0.72%)
TRI : 105.53 (-0.33%)
COIN : 186.49 (+8.20%)
STX : 850.00 (-0.03%)
WDC : 459.44 (-2.05%)
AMD : 473.25 (+0.81%)
CMC : 66.31 (+1.58%)
SCCO : 216.00 (+8.69%)
Huge Unusual Put Options Volume in Merck - Is MRK Stock Overvalued?

A Barchart report shows that despite recent strong Q2 results and a 10% spike in Merck stock today, an unusually large volume of put options has traded at a much lower strike price. Is MRK stock overvalued?...

MRK : 152.55 (+2.39%)
Merck (MRK) Stock Trades Up, Here Is Why

Merck (MRK) Stock Trades Up, Here Is Why

MRK : 152.55 (+2.39%)
This Analyst Just Upgraded Moderna as MRNA Stock Skyrockets on Cancer Vaccine Results

Moderna stock rips higher on a major cancer breakthrough. The announcement led William Blair to upgrade MRNA shares to "Outperform."

MRK : 152.55 (+2.39%)
MRNA : 145.13 (+8.86%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength is above 70%. The market is in overbought territory. Watch for a potential trend reversal.

See More Share

Business Summary

Merck & Co. boasts more than six blockbuster drugs in its portfolio with PD-L1 inhibitor, Keytruda, approved for several types of cancer. Keytruda has played an instrumental role in driving Merck's steady revenue growth in the past few years. Well-known products in Merck's portfolio include Keytruda,...

See More

Key Turning Points

3rd Resistance Point 161.06
2nd Resistance Point 157.78
1st Resistance Point 155.16
Last Price 152.55
1st Support Level 149.26
2nd Support Level 145.98
3rd Support Level 143.36

See More

52-Week High 154.49
Last Price 152.55
Fibonacci 61.8% 125.11
Fibonacci 50% 116.04
Fibonacci 38.2% 106.96
52-Week Low 77.58

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.